الابحاث

South Egypt Cancer Institute

Assiut University

Department of Clinical Pathology
# Title Research Member Research Year
51 Micro-RNA 155 in non-Hodgkin lymphoma ميرنا وجيه وديع ناروز 2021
52 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2021
53 Knowledge, perceptions and attitude of Egyptian physicians towards biobanking issues Prof. Douaa Mohamed Sayed Hussein 2021
54 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Dr. Mohamed Galal Mostafa ELnaggar 2021
55 Clinical Outcome of Pediatric Acute Myeloid Leukemia Treated at South Egypt Cancer Institute, Assiut University, Egypt Dr. Iman Hassan Ahmed Hamada 2021
56 Clinical Outcome of Pediatric Acute Myeloid Leukemia Treated at South Egypt Cancer Institute, Assiut University, Egypt Dr. Iman Hassan Ahmed Hamada 2021
57 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
 		Dr. Asmaa Mohamed Zahran Omar 2021
58 Relationship of transitional regulatory B and regulatory T cells and immunosuppressive drug doses in stable renal transplant recipients Prof. Douaa Mohamed Sayed Hussein 2021
59 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2021
60 Detection of del (16q) using the CBFB-MYH11 translocation dual fusion probe Dr. Doaa Fathi Hagag Ahmed 2021